PHASQ PhaseBio Pharmaceuticals (PNK) plunges 99.00% on 20 Jan 2026: liquidity risk needs monitoring

PHASQ stock collapsed about -99.00% to roughly $0.000001 on 20 Jan 2026 during US market hours, highlighting severe liquidity strain for PhaseBio Pharmaceuticals, Inc. (PNK). Trading volume was light at 2,500.00 shares versus an average of 22,310.00, and the previous close was $0.0001. The steep move follows continued delisting and Chapter 11 concerns, driving near-zero market capitalization and extreme volatility for this biotechnology name in the United States.